Patents-Review.com
ClassID:

109056 ⎘

C12N15/115 - page 4 - CPC Classification

Classification description:

Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers

Recent Application in this class:
#901
20200199193
2020-06-25

Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers

 #902
20200199168
2020-06-25

Class A GPCR-binding compound modifier

 #903
20200190160
2020-06-18

PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS

 #904
20200181720
2020-06-11

CRISPR effector system based diagnostics for virus detection

 #905
20200181620
2020-06-11

INHIBITORS OF DEK PROTEIN AND RELATED METHODS

 #906
20200181619
2020-06-11

Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation

 #907
20200181618
2020-06-11

Fluorogen-binding RNA aptamers

 #908
20200181617
2020-06-11

Chemically modified RNA aptamers and uses thereof

 #909
20200181264
2020-06-11

BISPECIFIC ANTIGEN-BINDING MOLECULE

 #910
20200181233
2020-06-11

Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers

 #911
20200172910
2020-06-04

Methods of treating neurodegenerative disease by inhibiting N-deacetylase N-sulfotransferase

 #912
20200172907
2020-06-04

Method for isolating cross-reactive aptamer and use thereof

 #913
20200172906
2020-06-04

Functional ligands to LL37

 #914
20200172905
2020-06-04

RNA aptamers against transferrin receptor (TfR)

 #915
20200171068
2020-06-04

COMPOSITIONS COMPRISING APTAMERS AND NUCLEIC ACID PAYLOADS AND METHODS OF USING THE SAME

 #916
20200165612
2020-05-28

Compositions and methods for the treatment of complications and disorders relating to Von Willebrand Factor

 #917
20200164053
2020-05-28

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

 #918
20200157544
2020-05-21

SBE aptamers for treating IL-17a related diseases and conditions

 #919
20200157543
2020-05-21

Biomolecule imaging method using aptamer

 #920
20200157542
2020-05-21

Bispecific aptamer for treating cancer

 #921
20200157177
2020-05-21

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

 #922
20200157162
2020-05-21

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

 #923
20200155603
2020-05-21

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

 #924
20200155602
2020-05-21

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

 #925
20200149046
2020-05-14

Compositions and methods for tagging ribonucleic acids

 #926
20200147192
2020-05-14

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

 #927
20200147190
2020-05-14

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

 #928
20200146269
2020-05-14

METHODS AND COMPOSITIONS FOR MODULATING INNATE LYMPHOID CELL PATHOGENIC EFFECTORS

 #929
20200141839
2020-05-07

Methods, compositions, and devices involving pseudoknot formation

 #930
20200140937
2020-05-07

Compositions, methods, and kits for amplifying nucleic acids

 #931
20200138924
2020-05-07

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

 #932
20200131515
2020-04-30

Aptamers for measuring lipoprotein levels

 #933
20200131514
2020-04-30

Method for isolating cross-reactive aptamer and use thereof

 #934
20200123567
2020-04-23

A UNIVERSAL PLATFORM TO ENHANCE CRISPR-BASED GENE EDITING FOR IN VIVO THERAPIES

 #935
20200123547
2020-04-23

NUCLEIC ACID-BASED ASSEMBLY AND USES THEREOF

 #936
20200116711
2020-04-16

Method and kit for simultaneous detection of multi target molecules using magnetic bead-aptamer conjugate

 #937
20200102359
2020-04-02

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

 #938
20200095636
2020-03-26

Antidote-mediated reversal of extracellular aptamer staining

 #939
20200093906
2020-03-26

Peptides and combination of peptides for use in immunotherapy against various cancers

 #940
20200087683
2020-03-19

Regulation of gene expression by aptamer-mediated modulation of alternative splicing

 #941
20200085944
2020-03-19

RNA VACCINE AND IMMUNE CHECKPOINT INHIBITORS FOR COMBINED ANTICANCER THERAPY

 #942
20200085930
2020-03-19

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS

 #943
20200080089
2020-03-12

High-Throughput Aptamer Screening Assay

 #944
20200080083
2020-03-12

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

 #945
20200080081
2020-03-12

A METHOD FOR REGULATING THE FUNCTION OF A HEART CELL, RELATED NUCLEOTIDES AND COMPOUNDS

 #946
20200072821
2020-03-05

IN VITRO SCREENING AND SELECTION OF SPECIFIC DNA APTAMERS AGAINST THE NON-HUMAN SIALIC ACID, N-GLYCOLYL NEURAMINIC ACID (NEU5GC)

 #947
20200071759
2020-03-05

Method for detecting target molecule in which rolling circle amplification is used

 #948
20200071701
2020-03-05

Method of modulating the number and the distribution of tumor-infiltrating leukocytes in tumors

 #949
20200071379
2020-03-05

Uterine cancer treatments

 #950
20200063137
2020-02-27

Riboswitch modulated gene therapy for retinal diseases

 #951
20200061171
2020-02-27

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

 #952
20200061170
2020-02-27

Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers

 #953
20200058369
2020-02-20

Quantitative Cluster Analysis Method Of Target Protein By Using Next-Generation Sequencing And Use Thereof

 #954
20200056236
2020-02-20

Methods for detection of RNase activity

 #955
20200056182
2020-02-20

Regulation of gene expression by aptamer-modulated RNase p cleavage

 #956
20200056181
2020-02-20

Post-selex modification methods

 #957
20200055899
2020-02-20

PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS

 #958
20200055898
2020-02-20

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

 #959
20200054729
2020-02-20

Method of treating with a peptide

 #960
20200054727
2020-02-20

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

 #961
20200048320
2020-02-13

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

 #962
20200046819
2020-02-13

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

 #963
20200041497
2020-02-06

Analyte detection method

 #964
20200040401
2020-02-06

METHOD FOR DETERMINING, PREDICTING AND TREATING CANCER

 #965
20200040057
2020-02-06

IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS

 #966
20200040050
2020-02-06

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

 #967
20200033332
2020-01-30

THIOLATED AROMATIC BLOCKING STRUCTURES FOR EAB BIOSENSORS

 #968
20200032266
2020-01-30

Compositions for Selection of Aptamers

 #969
20200032265
2020-01-30

Oligonucleotide Probes and Uses Thereof

 #970
20200031950
2020-01-30

Lin28-mediated control of let-7 biogenesis

 #971
20200024648
2020-01-23

Allergen detection

 #972
20200017858
2020-01-16

Regulation of gene expression through aptamer-modulated polyadenylation

 #973
20200010833
2020-01-09

Modified L-Nucleic Acid

 #974
20200010529
2020-01-09

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

 #975
20200009237
2020-01-09

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

 #976
20200002703
2020-01-02

Aptamers for personal care applications

 #977
20200000936
2020-01-02

BLOCK COPOLYMERS AND USES THEREOF

 #978
20200000934
2020-01-02

CONJUGATES COMPRISING OCULAR ANGIOGENESIS GROWTH FACTOR APTAMERS AND USES THEREOF IN THE DETECTION AND TREATMENT OF OPHTHALMOLOGICAL ANGIOGENESIS INDICATIONS

 #979
20200000902
2020-01-02

Peptides and combination of peptides for use in immunotherapy against various cancers

 #980
20200000900
2020-01-02

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

 #981
20200000850
2020-01-02

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

 #982
20200000849
2020-01-02

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

 #983
20200000848
2020-01-02

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

 #984
20200000697
2020-01-02

APTAMERS FOR HAIR CARE APPLICATIONS

 #985
20190390199
2019-12-26

Aptamers for use in inhibition and/or suppression of TLR9 activation

 #986
20190389931
2019-12-26

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

 #987
20190389930
2019-12-26

IMMUNOTHERAPY AGAINST MELANOMA AND OTHER CANCERS

 #988
20190388531
2019-12-26

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

 #989
20190388530
2019-12-26

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

 #990
20190382823
2019-12-19

Use of aptamers in proteomics

 #991
20190382766
2019-12-19

Functional ligands to drug compounds

 #992
20190382765
2019-12-19

Nucleoside derivative or salt thereof, polynucleotide synthesis reagent, method for producing polynucleotide, polynucleotide, and method for producing binding nucleic acid molecule

 #993
20190382764
2019-12-19

Electrochemical detection nanostructure, systems, and uses thereof

 #994
20190381103
2019-12-19

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

 #995
20190381088
2019-12-19

Anti-IL-17 aptamer having improved retention in blood

 #996
20190381087
2019-12-19

METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS

 #997
20190376987
2019-12-12

Methods for generating structure-switching aptamers and uses thereof

 #998
20190376051
2019-12-12

Permanent gene correction by means of nucleotide-modified messenger RNA

 #999
20190374626
2019-12-12

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

 #1000
20190367921
2019-12-05

Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same

 #1001
20190367903
2019-12-05

Oligonucleotide probes and uses thereof

 #1002
20190364872
2019-12-05

System and method for identifying the presence of insects

 #1003
20190361011
2019-11-28

Molecular design to suppress desorption of self-assembled monolayers

 #1004
20190359983
2019-11-28

TARGETED OLIGONUCLEOTIDES

 #1005
20190358202
2019-11-28

Aptamer-drug conjugate and use thereof

 #1006
20190352642
2019-11-21

Artificial chemical entity comprising a DNA oligonucleotide aptamer that selectively binds MUC1 antigen

 #1007
20190352640
2019-11-21

Ribosomal RNA origami and methods preparing thereof

 #1008
20190352359
2019-11-21

Peptides for use in immunotherapy against cancers

 #1009
20190351067
2019-11-21

Multifunctional RNA nanoparticles and methods for treating cancer and therapeutic resistant cancer

 #1010
20190345499
2019-11-14

Method for stabilizing DNA aptamers

 #1011
20190343867
2019-11-14

Bi-specific aptamer

 #1012
20190338284
2019-11-07

COMPLEX FOR DRUG DELIVERY AND STABILIZATION AND PREPARATION METHOD THEREOF

 #1013
20190336590
2019-11-07

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

 #1014
20190330634
2019-10-31

Method for generating aptamers with improved off-rates

 #1015
20190330633
2019-10-31

Building designer RNA nano-structures for synthetic biology applications

 #1016
20190330274
2019-10-31

PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS

 #1017
20190328856
2019-10-31

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

 #1018
20190324022
2019-10-24

Methods and systems for identifying candidate nucleic acid agent

 #1019
20190323012
2019-10-24

TNF-alpha-binding aptamer, and therapeutic use for same

 #1020
20190322722
2019-10-24

Immunotherapy against melanoma and other cancers

 #1021
20190322721
2019-10-24

Immunotherapy against melanoma and other cancers

 #1022
20190322716
2019-10-24

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

 #1023
20190322715
2019-10-24

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

 #1024
20190317099
2019-10-17

Aptamers and uses thereof

 #1025
20190316133
2019-10-17

Anti-Fibrinogen Aptamers and Uses Thereof

 #1026
20190316132
2019-10-17

Thermostable polymerase inhibitor compositions and methods

 #1027
20190315862
2019-10-17

Methods and pharmaceutical compositions for the prophylactic treatment of metastases

 #1028
20190315833
2019-10-17

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

 #1029
20190314477
2019-10-17

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

 #1030
20190314476
2019-10-17

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

 #1031
20190314475
2019-10-17

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

 #1032
20190314474
2019-10-17

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

 #1033
20190314473
2019-10-17

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

 #1034
20190309297
2019-10-10

Methods and compositions for the treatment of cancer

 #1035
20190309296
2019-10-10

Materials and methods for rapid and sensitive detection of small-molecule targets

 #1036
20190309075
2019-10-10

Methods for promoting t cells response by administering an antagonist of human c-type lectin-like receptor 1 (CLEC-1)

 #1037
20190307801
2019-10-10

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

 #1038
20190307784
2019-10-10

APTAMERS REDUCE SICKLE HEMOGLOBIN POLYMERIZATION

 #1039
20190292544
2019-09-26

Allergen detection agents and assays

 #1040
20190284560
2019-09-19

DNA aptamers binding to molecular targeted agents and detection method of molecular targeted medicine using the same

 #1041
20190284256
2019-09-19

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

 #1042
20190284250
2019-09-19

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

 #1043
20190276828
2019-09-12

CONJUGATES FOR SENSING

 #1044
20190275131
2019-09-12

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

 #1045
20190275129
2019-09-12

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

 #1046
20190270991
2019-09-05

Compositions for delivery of cargo to cells

 #1047
20190270984
2019-09-05

Methods and compositions for the making and using of guide nucleic acids

 #1048
20190270982
2019-09-05

Lactoferrin aptamers and use thereof

 #1049
20190270796
2019-09-05

THERAPEUTIC AGENT FOR PERIODONTITIS AND COMPOSTION FOR TREATING PERIODONTITIS

 #1050
20190270723
2019-09-05

Nucleic acid-binding photoprobes and uses thereof

 #1051
20190269770
2019-09-05

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

 #1052
20190269767
2019-09-05

Peptides and combination of peptides for use in immunotherapy against various cancers

 #1053
20190264208
2019-08-29

Method for Generating Aptamers with Improved Off-Rates

 #1054
20190262445
2019-08-29

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

 #1055
20190262444
2019-08-29

Peptides and combination of peptides for use in immunotherapy against various cancers

 #1056
20190262383
2019-08-29

CCR7 aptamers and uses thereof

 #1057
20190257831
2019-08-22

Biosensor for detecting the presence of bacteria

 #1058
20190256853
2019-08-22

Method for Obtaining Aptamers

 #1059
20190256852
2019-08-22

Materials and methods for rapid and specific detection of synthetic cathinones

 #1060
20190256546
2019-08-22

Therapeutic oligonucleotides

 #1061
20190255087
2019-08-22

ENCAPSULATION AND HIGH LOADING EFFICIENCY OF PHOSPHORYLATED DRUG AND IMAGING AGENTS IN NANOPARTICLES

 #1062
20190254958
2019-08-22

Drug delivery using aptamer construct

 #1063
20190249245
2019-08-15

Functional ligands to lipoarabinomannan

 #1064
20190248905
2019-08-15

NOVEL IGFR-LIKE RECEPTOR AND USES THEREOF

 #1065
20190248857
2019-08-15

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

 #1066
20190248826
2019-08-15

Nucleoside derivative or salt thereof, polynucleotide synthesis reagent, method for producing polynucleotide, polynucleotide, and method for producing binding nucleic acid molecule

 #1067
20190241895
2019-08-08

Secretory immunoglobulin a (sIgA)-binding nucleic acid molecule, sIgA analysis sensor, and sIgA analysis method

 #1068
20190241631
2019-08-08

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

 #1069
20190241630
2019-08-08

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

 #1070
20190240305
2019-08-08

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

 #1071
20190240248
2019-08-08

DNA NANOROBOT AND METHODS OF USE THEREOF

 #1072
20190233905
2019-08-01

Aptamers with binding affinity to norovirus

 #1073
20190233824
2019-08-01

PD-1 SPECIFIC APTAMERS

 #1074
20190233823
2019-08-01

Compounds for detecting and treating

#1075
20190233822
2019-08-01

Functional ligands to biocides

 #1076
20190233489
2019-08-01

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

 #1077
20190233488
2019-08-01

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

 #1078
20190233461
2019-08-01

5-POSITION MODIFIED PYRIMIDINES AND THEIR USE

 #1079
20190225961
2019-07-25

Compositions and methods relating to synthetic RNA polynucleotides created from synthetic DNA oligonucleotides

 #1080
20190225942
2019-07-25

CELL SCAFFOLD MATERIAL USING AN E-CADHERIN BINDING NUCLEIC ACID APTAMER

 #1081
20190225682
2019-07-25

METHOD OF TREATING LOCALIZED FIBROTIC DISORDERS USING AN IL-33/TNF BISPECIFIC ANTIBODY

 #1082
20190219595
2019-07-18

Personalized healthcare P4 cardiac health and wellness monitoring system and method utilizing TMAO and troponin

 #1083
20190218627
2019-07-18

Adeno-associated virus virions with variant capsid

 #1084
20190218608
2019-07-18

Hybridization chain reaction methods for in situ molecular detection

 #1085
20190218553
2019-07-18

Von Willebrand Factor (VWF)—targeting agents and methods of using the same

 #1086
20190211335
2019-07-11

Compositions, methods and systems for identifying candidate nucleic acid agent

 #1087
20190211334
2019-07-11

Aptamers specific for TLR-4 and uses thereof

 #1088
20190211048
2019-07-11

Nucleoside derivative or salt thereof, polynucleotide synthesis reagent, method for producing polynucleotide, polynucleotide, and method for producing binding nucleic acid molecule

 #1089
20190209670
2019-07-11

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

 #1090
20190209603
2019-07-11

Modulation of PCSK9 and LDLR through DRP1 inhibition

 #1091
20190209602
2019-07-11

MiRNA pharmaceutical compositions and therapeutic uses thereof

 #1092
20190202907
2019-07-04

METHOD OF TREATING SYSTEMIC FIBROTIC DISORDERS USING AN IL-33/TNF BISPECIFIC ANTIBODY

 #1093
20190201552
2019-07-04

Aptamer compositions and methods of use thereof

 #1094
20190201488
2019-07-04

COMPOSITIONS AND METHODS RELATING TO C5L2

 #1095
20190194289
2019-06-27

UTERINE CANCER TREATMENTS

 #1096
20190192571
2019-06-27

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

 #1097
20190185858
2019-06-20

Aptamer therapeutics useful in the treatment of complement-related disorders

 #1098
20190185845
2019-06-20

Aptamer methods and compositions

 #1099
20190177793
2019-06-13

Materials and methods for controlling gene expression

 #1100
20190177730
2019-06-13

Oligonucleotides comprising modified nucleosides

 #1101
20190177433
2019-06-13

Method of screening a candidate compound for activity as an elastase 2A (ELA2A) inhibitor

 #1102
20190177383
2019-06-13

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

 #1103
20190161756
2019-05-30

Anti-Immunoglobulin G Aptamers and Uses Thereof

 #1104
20190161755
2019-05-30

COMPOSITIONS AND METHODS FOR INHIBITING FACTOR D

 #1105
20190161526
2019-05-30

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

 #1106
20190153066
2019-05-23

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

 #1107
20190144539
2019-05-16

Methods and pharmaceutical compositions for the treatment of pulmonary bacterial infections

 #1108
20190136329
2019-05-09

Methods of detecting tumor cells

 #1109
20190136241
2019-05-09

APTAMER-BASED ANALYTE ASSAYS

 #1110
20190136240
2019-05-09

Nucleic acid aptamers

 #1111
20190136239
2019-05-09

Glypican-3 specific aptamer and use thereof

 #1112
20190128898
2019-05-02

Defective calcium signaling as a tool in autism spectrum disorders

 #1113
20190127739
2019-05-02

Self-assembled 3D RNA cage nanoparticles

 #1114
20190125882
2019-05-02

ISATOIC ANHYDRIDE DERIVATIVES AND APPLICATIONS THEREOF

 #1115
20190119682
2019-04-25

miRNA for treatment of breast cancer

 #1116
20190119681
2019-04-25

Methods and compositions for backscattering interferometry

 #1117
20190119342
2019-04-25

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

 #1118
20190117837
2019-04-25

MATRIX BOUND NANOVESICLES AND THEIR USE

 #1119
20190117748
2019-04-25

Glycosylated oligonucleotides that mimic the HIV-1 epitope of neutralizing monoclonal antibody 2G12

 #1120
20190117693
2019-04-25

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

 #1121
20190112605
2019-04-18

FUNCTIONAL LIGANDS TO IGG

 #1122
20190112601
2019-04-18

Oligomers

 #1123
20190112347
2019-04-18

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

 #1124
20190111081
2019-04-18

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

 #1125
20190106698
2019-04-11

METHOD FOR APTAMER PAIR SELECTION

 #1126
20190106452
2019-04-11

RNA nanoparticles for brain tumor treatment

 #1127
20190101529
2019-04-04

Tau protein-binding DNA aptamers with capture/detection and therapeutic utilities in tauopathy-related neurodegenerative disorders

 #1128
20190100581
2019-04-04

Optimized variants of anti-vegf antibodies and methods of use thereof in treatment

 #1129
20190100566
2019-04-04

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

 #1130
20190092824
2019-03-28

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

 #1131
20190092823
2019-03-28

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

 #1132
20190091689
2019-03-28

Microfluidic Device and Method for Isolation of Nucleic Acid

 #1133
20190091314
2019-03-28

Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers

 #1134
20190091313
2019-03-28

Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers

 #1135
20190091312
2019-03-28

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

 #1136
20190091311
2019-03-28

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

 #1137
20190085332
2019-03-21

DNA aptamers specific to CD2000R1 and their therapeutic uses

 #1138
20190085331
2019-03-21

Defined multi-conjugate oligonucleotides

 #1139
20190079063
2019-03-14

Systems and methods for allergen detection

 #1140
20190078094
2019-03-14

Aptamer specifically binding to L-Ascorbic acid and use of the same

 #1141
20190078093
2019-03-14

Oligonucleotide probes and uses thereof

 #1142
20190076514
2019-03-14

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

 #1143
20190076513
2019-03-14

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

 #1144
20190076457
2019-03-14

Nanoparticle to target cancer

 #1145
20190076406
2019-03-14

METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH ANGIOGENESIS USING A VASCULAR ADHESION PROTEIN-1 (VAP-1) INHIBITOR

 #1146
20190071714
2019-03-07

Aptamers for clostridium difficile detection

 #1147
20190071675
2019-03-07

INHIBITORS OF DEK PROTEIN AND RELATED METHODS

 #1148
20190071674
2019-03-07

Therapeutic strategies for ovarian cancer: AMHR2-RNA aptamer

 #1149
20190070279
2019-03-07

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

 #1150
20190062750
2019-02-28

Methods and pharmaceutical compositions for the treatment of filovirus infections

 #1151
20190062452
2019-02-28

Methods and Compositions for the Treatment of Immunomodulatory Diseases and Disorders

 #1152
20190062401
2019-02-28

Immunotherapy against melanoma and other cancers

 #1153
20190060431
2019-02-28

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

 #1154
20190060349
2019-02-28

TLX and MIR-219 as potential therapeutic targets for neurodevelopmental disorders

 #1155
20190055302
2019-02-21

Uterine cancer treatments

 #1156
20190055301
2019-02-21

Uterine cancer treatments

 #1157
20190054160
2019-02-21

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

 #1158
20190054156
2019-02-21

Stabilized thrombin

 #1159
20190048349
2019-02-14

APTAMERS FOR ORAL CARE APPLICATIONS

 #1160
20190048348
2019-02-14

Aptamers for consumer product compositions

 #1161
20190048347
2019-02-14

Nucleic acid aptamer AS1411 modified DNA tetrahedron and preparation method thereof

 #1162
20190040392
2019-02-07

TARGETED MRNA FOR IN VIVO APPLICATION

 #1163
20190040391
2019-02-07

Methods and compositions for selection of functional oligonucleotides

 #1164
20190040390
2019-02-07

POSH inhibitor complex biomolecules and amphiphile micelles

 #1165
20190040115
2019-02-07

Immunotherapy against melanoma and other cancers

 #1166
20190040114
2019-02-07

Immunotherapy against melanoma and other cancers

 #1167
20190040113
2019-02-07

Immunotherapy against melanoma and other cancers

 #1168
20190040112
2019-02-07

Immunotherapy against melanoma and other cancers

 #1169
20190032060
2019-01-31

Aptamer against insulin receptor and pharmaceutical compostion containing the same

 #1170
20190032056
2019-01-31

Stem-loop compositions and methods for inhibiting factor D

 #1171
20190032050
2019-01-31

RNA nanoparticle for treatment of gastric cancer

 #1172
20190031773
2019-01-31

INHIBITORS AND ANTAGONISTS OF HUMAN PYCR1

 #1173
20190031750
2019-01-31

Polynucleotides encoding optimized variants of anti-VEGF antibodies

 #1174
20190030174
2019-01-31

Ribonucleic acid aptamer having inhibitory effect on non-small cell lung cancer and pharmaceutical composition comprising same

 #1175
20190030075
2019-01-31

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

 #1176
20190024152
2019-01-24

Identification of selected spectrum antibiotics

 #1177
20190024087
2019-01-24

Nucleic acid compounds for binding growth differentiation factor 11

 #1178
20190023763
2019-01-24

Uterine cancer treatments

 #1179
20190015492
2019-01-17

Peptides and combination of peptides for use in immunotherapy against various cancers

 #1180
20190010544
2019-01-10

MOLECULAR ZIPPER TWEEZERS AND SPRING DEVICES

 #1181
20190010499
2019-01-10

METHODS FOR IMPROVED APTAMER SELECTION

 #1182
20190010498
2019-01-10

Chemically modified AMPA receptor RNA aptamers

 #1183
20190010198
2019-01-10

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

 #1184
20190008937
2019-01-10

Peptides and combination of peptides for use in immunotherapy against cancers

 #1185
20190002888
2019-01-03

FLT3 receptor antagonists for the treatment or the prevention of pain disorders

 #1186
20190002882
2019-01-03

MOLECULAR ROBOT

 #1187
20190000947
2019-01-03

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

 #1188
20180371462
2018-12-27

Compositions and methods for detecting microorganisms

 #1189
20180371461
2018-12-27

Aptamers, nucleic acid molecules, polynucleotides, synthetic antibodies compositions for detecting PRRS viruses and treating PRRS virus infection

 #1190
20180371460
2018-12-27

Depletion of Abundant Serum Proteins to Facilitate Biomarker Discovery

 #1191
20180360937
2018-12-20

Peptides and combination of peptides for use in immunotherapy against various cancers

 #1192
20180360936
2018-12-20

Peptides and combination of peptides for use in immunotherapy against various cancers

 #1193
20180356408
2018-12-13

METHODS AND MATERIALS FOR SENSITIVE DETECTION OF TARGET MOLECULES

 #1194
20180354987
2018-12-13

Method of isolation of polypeptide-aptamer-polymer conjugates

 #1195
20180353768
2018-12-13

Magnetic particle conjugates and methods of activating cell signaling

 #1196
20180353586
2018-12-13

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

 #1197
20180353585
2018-12-13

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

 #1198
20180353584
2018-12-13

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

 #1199
20180353583
2018-12-13

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

 #1200
20180348220
2018-12-06

DNA aptamer binding to cancer cell